Journal of Clinical Endocrinology & Metabolism, Vol 71, 1322-1329, Copyright © 1990 by Endocrine Society

ARTICLES

Studies of the mechanism by which androgens enhance mitogenesis and differentiation in bone cells

C Kasperk, R Fitzsimmons, D Strong, S Mohan, J Jennings, J Wergedal and D Baylink
Department of Medicine, Jerry L. Pettis Memorial Veterans Hospital, Loma Linda, California.

Recently, we reported a direct effect of androgens on murine and human bone cells to stimulate bone cell proliferation and differentiation. To test whether this effect of androgenic steroids might be mediated by growth factors, we measured relative concentrations of insulin-like growth factor-I and -II (IGF-I and IGF-II) and transforming growth factor-beta (TGF beta) in the conditioned medium from androgen-treated murine calvarial cell cultures. Only the concentration of TGF beta was increased. Consistent with the increased secretion of TGF beta in the mouse calvarial cell system, we observed an increased expression of TGF beta mRNA in a normal human osteoblastic cell system. We also determined whether androgens alter the response to growth factors. We found that dihydrotestosterone (DHT) treatment enhanced the mitogenic effects of fibroblast growth factor (FGF) and IGF-II but not those of IGF-I. The enhanced effect of FGF and IGF-II after DHT pretreatment was not affected by addition of TGF beta-blocking antibodies or by changing the culture medium. This indicated that in addition to increased release of TGF beta, another mechanism might be involved in the action of DHT on human and murine bone cells. Thus, we investigated the binding of human IGF-II to human osteoblastic cells and observed an increase in IGF-II binding after DHT treatment. Our results are consistent with a mechanism of action of androgens on bone cells that involves the induction of TGF beta and, in addition, may sensitize the cells to show an enhanced response to FGF and IGF-II, possibly by changing the receptor binding of mitogenic growth factors.

This article has been cited by other articles:

				K. Janssens, P. ten Dijke, S. Janssens, and W. Van Hul Transforming Growth Factor-{beta}1 to the Bone Endocr. Rev., October 1, 2005; 26(6): 743 - 774. [Abstract] [Full Text] [PDF]

				D. Vanderschueren, L. Vandenput, S. Boonen, M. K. Lindberg, R. Bouillon, and C. Ohlsson Androgens and Bone Endocr. Rev., June 1, 2004; 25(3): 389 - 425. [Abstract] [Full Text] [PDF]

				S. Issa, D. Schnabel, M. Feix, L. Wolf, H.-E. Schaefer, D. W. Russell, and H.-U. Schweikert Human Osteoblast-Like Cells Express Predominantly Steroid 5{alpha}-Reductase Type 1 J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5401 - 5407. [Abstract] [Full Text] [PDF]

				U. M. Liegibel, U. Sommer, P. Tomakidi, U. Hilscher, L. van den Heuvel, R. Pirzer, J. Hillmeier, P. Nawroth, and C. Kasperk Concerted Action of Androgens and Mechanical Strain Shifts Bone Metabolism from High Turnover into an Osteoanabolic Mode J. Exp. Med., November 18, 2002; 196(10): 1387 - 1392. [Abstract] [Full Text] [PDF]

				B. L. Riggs, S. Khosla, and L. J. Melton III Sex Steroids and the Construction and Conservation of the Adult Skeleton Endocr. Rev., June 1, 2002; 23(3): 279 - 302. [Abstract] [Full Text] [PDF]

				J.B. Dale, S.L. Sarich, T.M. Bretz, J.F. Hatton, and R.J. Zachow Hormonal Regulation of Androgen Receptor Messenger Ribonucleic Acid Expression in Human Tooth Pulp J. Dent. Res., May 1, 2002; 81(5): 360 - 365. [Abstract] [Full Text] [PDF]

				J. E. Compston Sex Steroids and Bone Physiol Rev, January 1, 2001; 81(1): 419 - 447. [Abstract] [Full Text] [PDF]

				R. Marcus, D. Leary, D. L. Schneider, E. Shane, M. Favus, and C. A. Quigley The Contribution of Testosterone to Skeletal Development and Maintenance: Lessons from the Androgen Insensitivity Syndrome J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 1032 - 1037. [Abstract] [Full Text]

				K. Wiren, E. Keenan, X. Zhang, B. Ramsey, and E. Orwoll Homologous Androgen Receptor Up-Regulation in Osteoblastic Cells May Be Associated with Enhanced Functional Androgen Responsiveness Endocrinology, July 1, 1999; 140(7): 3114 - 3124. [Abstract] [Full Text]

				L. Pederson, M. Kremer, J. Judd, D. Pascoe, T. C. Spelsberg, B. L. Riggs, and M. J. Oursler Androgens regulate bone resorption activity of isolated osteoclasts in vitro PNAS, January 19, 1999; 96(2): 505 - 510. [Abstract] [Full Text] [PDF]

				R. K. Gill, R. T. Turner, T. J. Wronski, and N. H. Bell Orchiectomy Markedly Reduces the Concentration of the Three Isoforms of Transforming Growth Factor {beta} in Rat Bone, and Reduction Is Prevented by Testosterone Endocrinology, February 1, 1998; 139(2): 546 - 550. [Abstract] [Full Text] [PDF]

				D. Vanderschueren, E. Van Herck, J. Nijs, A. G. H. Ederveen, R. De Coster, and R. Bouillon Aromatase Inhibition Impairs Skeletal Modeling and Decreases Bone Mineral Density in Growing Male Rats Endocrinology, June 1, 1997; 138(6): 2301 - 2307. [Abstract] [Full Text] [PDF]

				I. Vered, I. Kaiserman, B.-A. Sela, and J. Sack Cross Genotype Sex Hormone Treatment in Two Cases of Hypogonadal Osteoporosis J. Clin. Endocrinol. Metab., February 1, 1997; 82(2): 576 - 578. [Abstract] [Full Text] [PDF]

				C. J. Bagatell and W. J. Bremner Androgens in Men -- Uses and Abuses N. Engl. J. Med., March 14, 1996; 334(11): 707 - 715. [Full Text] [PDF]